Share Issue/Capital Change • Nov 21, 2016
Share Issue/Capital Change
Open in ViewerOpens in native device viewer
Deloitte Bedrijfsrevisoren / Reviseurs d'Entreprises Berkenlaan 8b 1831 Diegem Belgium Tel. + 32 2 800 20 00
Fax + 32 2 800 20 01 www.deloitte.be
Issuance of shares with cancellation of the preferential subscription right
Statutory auditor's report in accordance with article 596 of the Belgian Company Code
The original text of this report is in Dutch
Deloitte Bedrijfsrevisoren / Reviseurs d'Entreprises
Burgerlijke vennootschap onder de vorm van een coöperatieve vennootschap met beperkte aansprakelijkheid /
Société civile sous forme d'une société coopérative à responsab
Deloitte Bedrijfsrevisoren / Reviseurs d'Entreprises Berkenlaan 8b 1831 Diegem Belgium Tel. + 32 2 800 20 00 Fax + 32 2 800 20 01 www.deloitte.be
The original text of this report is in Dutch
To the board of directors of Biocartis Group NV (the 'company')
In accordance with article 596 of the Belgian Company Code, we have reviewed the attached special report of the board of directors of 16 November 2016. This report relates to the cancellation of the preferential subscription rights of the existing shareholders in favor of a currently unidentified group of institutional, qualified or professional investors (including, subject to applicable securities law rules and regulations, natural persons) in the framework of the proposed capital increase under the authorized capital for a maximum amount (excluding share premium) of 40,589.17 EUR.
The purpose of this report is $-$ according to said article $-$ the following:
Article 596:
"The general shareholders' meeting, which has to discuss and conclude on the capital increase, the issuance of convertible bonds or the issuance of warrants, can, taking into account the requirements with respect to quorum and majority required for an amendment to the articles of association, in the interest of the company, limit or cancel the preferential subscription right. The proposal thereto has to be specifically mentioned in the invitation.
The board of directors justifies its proposal in a detailed report that specifically relates to the issuance price and to the financial consequences of the transaction for the shareholders. A report has to be drafted by the statutory auditor or, in his absence, by a certified auditor assigned by the board of directors, or by an external accountant, assigned in the same way, in which he states that the financial and accounting information, included in the report of the board or directors, is accurate and sufficient to inform the general shareholders' meeting that has to vote on this proposal. The reports are deposited at the Court Registry of Commerce, in accordance with article 75. They are mentioned in the agenda. A copy can be obtained in accordance with article 535.
The absence of the reports mentioned in this article has the annulment of the decision of the general shareholders' meeting as a consequence.
The decision of the general shareholders' meeting to limit or cancel the preferential subscription right has to be deposited at the Court Registry of Commerce, in accordance with article 75."
In our opinion the financial and accounting information, in the attached special report of the board of directors as of 16 November 2016 is accurate and sufficient to inform the board of directors, who act in accordance with the authorized capital and ultimately the shareholders, on the proposed cancellation of the preferential subscription right of the existing shareholders in the framework of the proposed capital increase under the authorized capital for a maximum amount (excluding share premium) of 40,589.17 EUR.
This report is intended solely for the use of the board of directors and the shareholders of the company in the framework of the cancellation of the preferential subscription right as described above. It therefore cannot be used for any other purpose.
Diegem, 16 November 2016
The statutory auditor
DELOITTE Bedrijfsrevisoren / Reviseurs d'Entreprises BV o.v.v.e. CVBA / SC s.f.d. SCRL Represented by Gert Vanhees
Special report of the board of directors of 16 November 2016, in accordance with article 596 of the Code of Companies relating to the cancellation of the preferential subscription rights of the existing shareholders in favor of a currently unidentified group of institutional, qualified or professional investors (including, subject to applicable securities law rules and regulations, natural persons) in the framework of the proposed capital increase under the authorized capital for a maximum amount (excluding share premium) of 40,589.17 EUR.
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.